Alzheimer’s ‘wonder’ drug lecanemab set to get green light in UK marking ‘biggest breakthrough’ for decades
A “GAME-CHANGING” drug shown to slow the progression of Alzheimer’s is set to be approved in the UK. Lecanemab, developed by pharmaceutical company Eisai, is a targeted antibody treatment that …